Cardio Flashcards
HTN Guidelines?
1) ABPM/HBPM >= 135/85 mmHg (i.e. stage 1 hypertension)
treat if < 80 years of age AND any of the following apply;
- target organ damage,
- established cardiovascular disease,
- renal disease,
- diabetes or
- QRISK 20% or greater
2) ABPM/HBPM >= 150/95 mmHg (i.e. stage 2 hypertension)
- drug treatment regardless of age
If <40 consider specialist to exclude secondary causes
HTN Stepwise Management?
Step 1:
- patients < 55-years-old: ACE inhibitor (A)
- patients > 55-years-old or of Afro-Caribbean origin: calcium channel blocker
Step 2:
- ACE inhibitor + calcium channel blocker (A + C)
Step 3:
- Add a thiazide diuretic (D, i.e. A + C + D)
chlorthalidone (12.5-25.0 mg once daily) or
indapamide (1.5 mg modified-release once daily or 2.5 mg once daily)
Step 4 (Resistant):
1) consider further diuretic treatment
- if potassium < 4.5 mmol/l add spironolactone 25mg od
- if potassium > 4.5 mmol/l add higher-dose thiazide-like diuretic treatment
2) if further diuretic therapy is not tolerated, or is contraindicated or ineffective, consider an alpha- or beta-blocker
BP Targets?
Allskiren?
- Direct renin inhibitor
- Inhibiting renin blocks the conversion of angiotensinogen to angiotensin I
- Only current role would seem to be in patients who are intolerant of more established
antihypertensive drugs
Features of severe pre-eclampsia?
hypertension: typically > 170/110 mmHg and proteinuria as above
proteinuria: dipstick ++/+++
headache
visual disturbance
papilloedema
RUQ/epigastric pain
hyperreflexia
platelet count < 100 * 106/l, abnormal liver enzymes or HELLP syndrome
Centrally acting antihypertensives?
- methyldopa: used in the management of hypertension during pregnancy
- moxonidine: used in the management of essential hypertension when conventional
antihypertensives have failed to control blood pressure - clonidine: the antihypertensive effect is mediated through stimulating alpha-2 adrenoceptors in
the vasomotor centre
DM HTN targets?
if end-organ damage (e.g. renal disease, retinopathy) < 130/80 mmHg
otherwise < 140/80 mmHg
ACEi first line due to renoprotection - if african/caribbean ACEi plus thiazide or CCB
HF Guidelines?
1) ACE-inhibitor and a beta-blocker
2) aldosterone antagonist, angiotensin II receptor
blocker or a hydralazine in combination with a nitrate
3) if symptoms persist cardiac resynchronisation therapy or digoxin
Drugs that exacerbate HF?
1) thiazolidinediones: pioglitazone is contraindicated as it causes fluid retention
2) verapamil: negative inotropic effect
3) NSAIDs/glucocorticoids: should be used with caution as they cause fluid retention
4) class I antiarrhythmics; flecainide (negative inotropic and proarrhythmic effect)
Adverse effects of bendroflumethiazide?
Common
1) dehydration
2) postural hypotension
3) hyponatraemia, hypokalaemia, hypercalcaemia
4) gout
5) impaired glucose tolerance
6) impotence
Rare
1)thrombocytopaenia
2) agranulocytosis
3) photosensitivity rash
4) pancreatitis
Digoxin mechanism?
- decreases conduction through the atrioventricular node which slows the ventricular rate in atrial fibrillation and flutter
- Increases the force of cardiac muscle contraction due to inhibition of the Na+/K+ ATPase pump.
- Also stimulates vagus nerve
Digoxin toxicity?
generally unwell, lethargy, nausea & vomiting, anorexia, confusion, yellow-green vision
arrhythmias (e.g. AV block, bradycardia)
Precipitating factors
classically: hypokalaemia* ,hypomagnesaemia
hypercalcaemia, hypernatraemia, acidosis
hypoalbuminaemia
hypothermia
hypothyroidism
increasing age
renal failure
myocardial ischaemia
Precipitating Drugs:
Amiodarone, quinidine,
verapamil, diltiazem,
spironolactone (competes for secretion in distal convoluted tubule therefore reduce
excretion),
Ciclosporin.
Also drugs which cause hypokalaemia e.g. thiazides and loop diuretics
Dipyridamole mechanism?
inhibits phosphodiesterase, elevating platelet cAMP levels which in turn reduce
intracellular calcium levels
other actions include reducing cellular uptake of adenosine and inhibition of thromboxane
synthase
Arterial supply and venous drainage of heart?
ECG coronary territories?
Angina management?
- Aspirin and statin
- Sublingal GTN
- BB or CCB monotherapy
- Titrate up to maximum dose
- If still symptomatic add in CCB to BB and vice versa
(Monotherapy - rate limiting CCB, combination - dihydropyradine)
- If can’t tolerate combination therapy onsider long acting nitrate ivabradine, nicorandil or ranolazine
- if a patient is taking both a beta-blocker and a calcium-channel blocker then only add a third drug whilst a patient is awaiting assessment for PCI or CABG
Nitrate tolerance?
Ivabradine?
IV glycoprotein IIb/IIIa receptor antagonists?
Cardiac enzymes?
Glycaemic control in ACS?
Stent thrombosis vs Restenosis?
Thrombolysis contraindications?
Dressler’s syndrome?
MI Complications ?
- LV aneurysm
- LV free wall rupture
- VSD
- Acute MR
Reasons to stop stress test?
Special situations for lipi modification?
Diagnostic criteria for familial hypercholesterolaemia?
Remnant Hyperlipidaemia?
Characteristic xanothomata from different lipid disorders?
Myocarditis causes and presentation?
Tamponade features?
Differences between cardiac tamponade and constrictive pericarditis?
Restrictive Cardiomyopathy?
Dilated cardiomyopathy?